Catalyst Wire Dossier Catalyst Wire Dossier

ALG-000184

· Aligos Therapeutics
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for ALG-000184, covering 2025-02-03 to 2026-02-06. Get the full timeline:

Most recent: Clinical Trial Update: A Study Evaluating the Efficacy and Safety of ALG-000184 Compared With Tenofovir Disoproxil Fumarate in Untreated HBeAg-Positive and HBeAg- Negative Adult Subjects With Chronic Hepatitis B (B-SUPREME) [Phase 2]

See pricing